Clinical Research Education in Genome Science (CREiGS)
Clinical Research Education in Genome Science (CREiGS)
批准号:
10580752
负责人:
Emma Katherine Tara Benn
金额:
$16.2万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-05-01 至 2025-02-28
关键词:
AccelerationAreaBiomedical ResearchCellsClinicalClinical DataClinical ResearchCommunitiesCompetenceComplexCritical ThinkingDataData AnalysesDevelopmentEducationEducational CurriculumEducational process of instructingEnsureExerciseFacultyFoundationsFutureGene ExpressionGeneticGenomic medicineGenomicsGoalsHealthHourHumanHybridsInstitutionKnowledgeLogisticsMachine LearningMedicalMethodologyMethodsMissionNational Human Genome Research InstituteOutcomeParticipantPatient CarePatientsPersonsPhasePhenotypePlayPostdoctoral FellowProblem SolvingProteomicsProviderRecruitment ActivityReproducibilityResearchResearch MethodologyResearch PersonnelResourcesRoleSingle Nucleotide PolymorphismSolidStatistical MethodsStudentsTechnologyTissuesTrainingTranslational ResearchTreatment outcomeUnderrepresented MinorityUnderserved PopulationUpdatecancer therapyclinical carecomputerized toolsdata managementdisease phenotypedisorder subtypedoctoral studenteducation researchefficacy evaluationgenetic analysisgenome sciencesgenomic datagrasphealth disparityimprovedindividual patientinnovationlecturesmachine learning methodminority investigatoroperationpersonalized medicineprecision medicineprogramsrecruitresponsescience educationstatistical and machine learningsuccesstheoriestherapy developmenttooltranscriptomicstreatment optimizationvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
The sensitivity and availability of omic technologies have enabled the genomic, transcriptomic
and proteomic characterization of disease phenotypes, at the tissue and even the single cell level. This has
allowed development of treatments that target specific disease subtypes, most notably in cancer
treatment, and thus opened up opportunities for the development of precision/personalized medicine
strategies for optimizing treatments for individual patients. Thus, new genomic science educational initiatives
need to be continually updated to educate the clinical and translational workforce on how to effectively
interpret and apply the findings from genomics studies. Patients of providers who have participated in these
educational initiatives also benefit as it allows for more rapid integration of genomic study findings into the
clinical care setting. Thus, in response to PAR-19-185, we propose to develop and implement the
Clinical Research Education in Genome Science (CREiGS) program that will not only focus on the
analysis of genomic data, but also on gene-expression data, the integration of these two data types, as well
as introductory theory and application of statistical and machine learning methods. Specifically we
propose to accomplish the following specific aims:
1. Develop and successfully implement the online and in-person phases of CREiGS to increase the
methodologic ingenuity by which researchers tackle important genomics-related clinical problems.
2. Establish a Diversity Recruitment External Advisory Board to ensure that the most effective strategies
are employed to recruit URM doctoral students, postdoctoral fellows, and faculty from academic institutions
nationwide into CREiGS.
3. Enhance the dissemination phase of CREiGS by packaging and uploading the asynchronous lectures
and the online critical thinking/problem solving assessments with solutions for publicly available, online
teaching resources.
4. Implement effective methods to evaluate the efficacy of CREiGS by examining:1) the participants' grasp
of the CREiGS core competencies, 2) the clarity and quality of the curriculum, 3) program logistics and
operation, and 4) the participants' short-term and long-term success attributed to participation in CREiGS.
In summary, we posit that CREiGS will provide participants with a solid foundation in genomics science to
answer complex, clinical questions. We believe that CREiGS supports the mission of the NHGRI by providing
researchers with rigorous training to “accelerate medical breakthroughs that improve human health.”
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NIH FIRST Cohort Cluster Hiring Initiative at Icahn School of Medicine at Mount Sinai
-
批准号:10494239
-
项目类别:
-
资助金额:$549.93万
-
财政年份:2021
-
负责人:Emma Katherine Tara Benn
-
依托单位:
NIH FIRST Cohort Cluster Hiring Initiative at Icahn School of Medicine at Mount Sinai
-
批准号:10696174
-
项目类别:
-
资助金额:$548.15万
-
财政年份:2021
-
负责人:Emma Katherine Tara Benn
-
依托单位:
Administrative Core
-
批准号:10494240
-
项目类别:
-
资助金额:$505.33万
-
财政年份:2021
-
负责人:Emma Katherine Tara Benn
-
依托单位:
Cancer research education program (C-REP)
-
批准号:10302840
-
项目类别:
-
资助金额:$14.95万
-
财政年份:2021
-
负责人:Emma Katherine Tara Benn
-
依托单位:
Administrative Core
-
批准号:10362242
-
项目类别:
-
资助金额:$20.68万
-
财政年份:2021
-
负责人:Emma Katherine Tara Benn
-
依托单位:
Cancer research education program (C-REP)
-
批准号:10686195
-
项目类别:
-
资助金额:$15.84万
-
财政年份:2021
-
负责人:Emma Katherine Tara Benn
-
依托单位:
NIH FIRST Cohort Cluster Hiring Initiative at Icahn School of Medicine at Mount Sinai
-
批准号:10362241
-
项目类别:
-
资助金额:$49.93万
-
财政年份:2021
-
负责人:Emma Katherine Tara Benn
-
依托单位:
Administrative Core
-
批准号:10696175
-
项目类别:
-
资助金额:$503.7万
-
财政年份:2021
-
负责人:Emma Katherine Tara Benn
-
依托单位:
Clinical Research Education in Genome Science (CREiGS)
-
批准号:10359733
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2020
-
负责人:Emma Katherine Tara Benn
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: